Saturday, July 11, 2026

pharma · Gastric Cancer

Eastern Hepatobiliary Surgery

Eastern Hepatobiliary Surgery clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
4
Patents
0
Intelligence · Clinical Programs

Eastern Hepatobiliary Surgery projects

1 ClinicalTrials.gov programs sponsored by Eastern Hepatobiliary Surgery.

Eastern Hepatobiliary Surgery has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ENCITJ-GC01

    Eastern Hepatobiliary Surgery Hospital

    Gastric Cancer

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Eastern Hepatobiliary Surgery have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.